Minerva Neurosciences (NERV) Invested Capital (2013 - 2018)

Minerva Neurosciences (NERV) has 5 years of Invested Capital data on file, last reported at $3.5 million in Q4 2017.

• Quarterly Invested Capital fell 58.59% year-over-year to $3.5 million in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $3.5 million (down 86.79% YoY) and the FY2017 annual result came in at $3.5 million, down 58.59% from the prior year.
• Invested Capital slipped to $3.5 million in Q4 2017, from $4.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.0 million in Q2 2015 to a low of $2.0 million in Q4 2013.
• A 5-year average of $7.2 million and a median of $8.4 million in 2016 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2015 — Invested Capital surged 402.07% — and 2017, when it sank 58.59%.
• Tracing NERV's Invested Capital over 5 years: stood at $2.0 million in 2013, then climbed by 0.92% to $2.0 million in 2014, then surged by 402.07% to $10.0 million in 2015, then dropped by 15.71% to $8.4 million in 2016, then slumped by 58.59% to $3.5 million in 2017.
• The last three Invested Capital figures came in at $3.5 million (Q4 2017), $4.8 million (Q3 2017), and $6.0 million (Q2 2017), per Business Quant data.